supplementhackr
Primeval Labs

Mega Test

Serving
5 Capsule(s)
Per container
30
Form
capsule-unknown
DSLD
172765
Caution-flaggedObjective label signals
Flagged excipients
5
0 avoid · 5 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
5 excipients carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

9 active ingredients
IngredientAmount% DV
D-Aspartic Acid, Powder
D-Aspartic AcidUNII · 4SR0Q8YD1X
2000 mg—
Tribulus terrestris
TribulusUNII · 4X4HLN92OT
750 mg—
Maca root powder
Maca
250 mg—
Fenugreek
UNII · 654825W09Z
200 mg—
Magnesium
UNII · I38ZP9992A
150 mg—
Long Jack root powder
Eurycoma Longifolia
100 mg—
ARIMISTANE
Arimistane
25 mg—
Zinc Oxide
ZincUNII · SOI2LOH54Z
10 mg—
Vitamin D3
Vitamin DUNII · 1C6V77QF41
1000 IU—
Flagged excipients

5 flagged · authority citations

  • ◐ CAUTIONFD&C Blue #1
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

    eur-lex.europa.eu →
  • ◐ CAUTIONFD&C Green #3
    color

    Banned in EU countries (not listed in Reg 1333/2008 Annex II). Permitted in US under 21 CFR 74.203. Used in some capsule coatings.

    ecfr.gov →
  • ◐ CAUTIONFD&C Red #3
    color

    FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.

    fda.gov →federalregister.gov →
  • ◐ CAUTIONFD&C Red #40
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

    eur-lex.europa.eu →leginfo.legislature.ca.gov →
  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Microcrystalline Cellulose · Magnesium Stearate